nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CES2—Irinotecan—colon cancer	0.679	0.736	CbGbCtD
Prasugrel—CYP2B6—Irinotecan—colon cancer	0.0453	0.0491	CbGbCtD
Prasugrel—ALB—Irinotecan—colon cancer	0.0444	0.0481	CbGbCtD
Prasugrel—ALB—Fluorouracil—colon cancer	0.0426	0.0462	CbGbCtD
Prasugrel—CYP2C9—Capecitabine—colon cancer	0.0387	0.042	CbGbCtD
Prasugrel—ALB—Methotrexate—colon cancer	0.0235	0.0255	CbGbCtD
Prasugrel—CYP2C9—Fluorouracil—colon cancer	0.023	0.0249	CbGbCtD
Prasugrel—CYP3A4—Irinotecan—colon cancer	0.0139	0.0151	CbGbCtD
Prasugrel—CYP3A4—Vincristine—colon cancer	0.0122	0.0132	CbGbCtD
Prasugrel—Clopidogrel—ABCB1—colon cancer	0.00226	1	CrCbGaD
Prasugrel—P2RY12—epithelium—colon cancer	0.00205	0.135	CbGeAlD
Prasugrel—Haematochezia—Capecitabine—colon cancer	0.00186	0.031	CcSEcCtD
Prasugrel—Pericardial effusion—Capecitabine—colon cancer	0.00183	0.0305	CcSEcCtD
Prasugrel—ALB—gall bladder—colon cancer	0.00144	0.0953	CbGeAlD
Prasugrel—Pericardial effusion—Methotrexate—colon cancer	0.00136	0.0227	CcSEcCtD
Prasugrel—Neoplasm malignant—Irinotecan—colon cancer	0.00131	0.0219	CcSEcCtD
Prasugrel—CES2—smooth muscle tissue—colon cancer	0.00126	0.0829	CbGeAlD
Prasugrel—CES2—renal system—colon cancer	0.00121	0.0798	CbGeAlD
Prasugrel—Haematoma—Capecitabine—colon cancer	0.00119	0.0199	CcSEcCtD
Prasugrel—Haemoptysis—Capecitabine—colon cancer	0.00101	0.0169	CcSEcCtD
Prasugrel—Neoplasm—Irinotecan—colon cancer	0.00101	0.0169	CcSEcCtD
Prasugrel—CES2—digestive system—colon cancer	0.000993	0.0655	CbGeAlD
Prasugrel—CES2—bone marrow—colon cancer	0.000915	0.0604	CbGeAlD
Prasugrel—CES2—vagina—colon cancer	0.000877	0.0578	CbGeAlD
Prasugrel—Contusion—Capecitabine—colon cancer	0.00086	0.0143	CcSEcCtD
Prasugrel—Pain in extremity—Vincristine—colon cancer	0.000835	0.0139	CcSEcCtD
Prasugrel—Rectal haemorrhage—Capecitabine—colon cancer	0.00083	0.0138	CcSEcCtD
Prasugrel—Cerebrovascular accident—Irinotecan—colon cancer	0.00083	0.0138	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.000813	0.0136	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.000779	0.013	CcSEcCtD
Prasugrel—CES2—liver—colon cancer	0.000739	0.0488	CbGeAlD
Prasugrel—Neoplasm—Capecitabine—colon cancer	0.000678	0.0113	CcSEcCtD
Prasugrel—Ecchymosis—Capecitabine—colon cancer	0.000678	0.0113	CcSEcCtD
Prasugrel—Atrial fibrillation—Capecitabine—colon cancer	0.000575	0.00958	CcSEcCtD
Prasugrel—Bradycardia—Irinotecan—colon cancer	0.000573	0.00955	CcSEcCtD
Prasugrel—Urinary tract disorder—Vincristine—colon cancer	0.000571	0.00952	CcSEcCtD
Prasugrel—CES2—lymph node—colon cancer	0.000567	0.0374	CbGeAlD
Prasugrel—Urethral disorder—Vincristine—colon cancer	0.000566	0.00945	CcSEcCtD
Prasugrel—Epistaxis—Fluorouracil—colon cancer	0.000566	0.00944	CcSEcCtD
Prasugrel—Haemoglobin—Irinotecan—colon cancer	0.000566	0.00943	CcSEcCtD
Prasugrel—Haemorrhage—Irinotecan—colon cancer	0.000563	0.00938	CcSEcCtD
Prasugrel—Cerebrovascular accident—Capecitabine—colon cancer	0.000556	0.00926	CcSEcCtD
Prasugrel—Pain in extremity—Capecitabine—colon cancer	0.000544	0.00908	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000544	0.00908	CcSEcCtD
Prasugrel—Haemoglobin—Fluorouracil—colon cancer	0.000542	0.00903	CcSEcCtD
Prasugrel—Haemorrhage—Fluorouracil—colon cancer	0.000539	0.00899	CcSEcCtD
Prasugrel—Angiopathy—Vincristine—colon cancer	0.000524	0.00874	CcSEcCtD
Prasugrel—Mediastinal disorder—Vincristine—colon cancer	0.000521	0.00868	CcSEcCtD
Prasugrel—Angiopathy—Irinotecan—colon cancer	0.000511	0.00851	CcSEcCtD
Prasugrel—Immune system disorder—Irinotecan—colon cancer	0.000508	0.00848	CcSEcCtD
Prasugrel—Mediastinal disorder—Irinotecan—colon cancer	0.000507	0.00846	CcSEcCtD
Prasugrel—Ecchymosis—Methotrexate—colon cancer	0.000505	0.00842	CcSEcCtD
Prasugrel—Neoplasm—Methotrexate—colon cancer	0.000505	0.00842	CcSEcCtD
Prasugrel—Back pain—Vincristine—colon cancer	0.000487	0.00811	CcSEcCtD
Prasugrel—Back pain—Irinotecan—colon cancer	0.000474	0.0079	CcSEcCtD
Prasugrel—Anaemia—Vincristine—colon cancer	0.000465	0.00775	CcSEcCtD
Prasugrel—CYP2C19—digestive system—colon cancer	0.000457	0.0302	CbGeAlD
Prasugrel—Anaemia—Irinotecan—colon cancer	0.000453	0.00755	CcSEcCtD
Prasugrel—Leukopenia—Vincristine—colon cancer	0.00045	0.00751	CcSEcCtD
Prasugrel—Leukopenia—Irinotecan—colon cancer	0.000438	0.00731	CcSEcCtD
Prasugrel—CYP2B6—renal system—colon cancer	0.000437	0.0288	CbGeAlD
Prasugrel—Hypertension—Vincristine—colon cancer	0.000434	0.00724	CcSEcCtD
Prasugrel—Anaemia—Fluorouracil—colon cancer	0.000434	0.00723	CcSEcCtD
Prasugrel—Cough—Irinotecan—colon cancer	0.000427	0.00713	CcSEcCtD
Prasugrel—ALB—liver—colon cancer	0.000423	0.0279	CbGeAlD
Prasugrel—Hypertension—Irinotecan—colon cancer	0.000423	0.00705	CcSEcCtD
Prasugrel—Leukopenia—Fluorouracil—colon cancer	0.00042	0.007	CcSEcCtD
Prasugrel—Cerebrovascular accident—Methotrexate—colon cancer	0.000414	0.0069	CcSEcCtD
Prasugrel—Anaphylactic shock—Vincristine—colon cancer	0.000411	0.00685	CcSEcCtD
Prasugrel—CYP2C19—vagina—colon cancer	0.000404	0.0267	CbGeAlD
Prasugrel—Thrombocytopenia—Vincristine—colon cancer	0.000402	0.0067	CcSEcCtD
Prasugrel—Haematuria—Capecitabine—colon cancer	0.0004	0.00667	CcSEcCtD
Prasugrel—Anaphylactic shock—Irinotecan—colon cancer	0.0004	0.00667	CcSEcCtD
Prasugrel—Epistaxis—Capecitabine—colon cancer	0.000396	0.0066	CcSEcCtD
Prasugrel—Thrombocytopenia—Irinotecan—colon cancer	0.000391	0.00653	CcSEcCtD
Prasugrel—Hypotension—Vincristine—colon cancer	0.000384	0.0064	CcSEcCtD
Prasugrel—Bradycardia—Capecitabine—colon cancer	0.000383	0.00639	CcSEcCtD
Prasugrel—Anaphylactic shock—Fluorouracil—colon cancer	0.000383	0.00639	CcSEcCtD
Prasugrel—Haemoglobin—Capecitabine—colon cancer	0.000379	0.00631	CcSEcCtD
Prasugrel—Haemorrhage—Capecitabine—colon cancer	0.000377	0.00628	CcSEcCtD
Prasugrel—Thrombocytopenia—Fluorouracil—colon cancer	0.000375	0.00625	CcSEcCtD
Prasugrel—Hypotension—Irinotecan—colon cancer	0.000374	0.00623	CcSEcCtD
Prasugrel—Urinary tract disorder—Capecitabine—colon cancer	0.000372	0.0062	CcSEcCtD
Prasugrel—Oedema peripheral—Capecitabine—colon cancer	0.000371	0.00619	CcSEcCtD
Prasugrel—Urethral disorder—Capecitabine—colon cancer	0.000369	0.00616	CcSEcCtD
Prasugrel—CYP2B6—lymphoid tissue—colon cancer	0.000363	0.0239	CbGeAlD
Prasugrel—CYP2B6—digestive system—colon cancer	0.000358	0.0236	CbGeAlD
Prasugrel—Hypotension—Fluorouracil—colon cancer	0.000358	0.00597	CcSEcCtD
Prasugrel—Dyspnoea—Irinotecan—colon cancer	0.000356	0.00594	CcSEcCtD
Prasugrel—CYP2C9—digestive system—colon cancer	0.000355	0.0234	CbGeAlD
Prasugrel—Gastrointestinal disorder—Vincristine—colon cancer	0.000354	0.00591	CcSEcCtD
Prasugrel—Fatigue—Vincristine—colon cancer	0.000354	0.0059	CcSEcCtD
Prasugrel—Eye disorder—Capecitabine—colon cancer	0.000352	0.00587	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Irinotecan—colon cancer	0.000345	0.00576	CcSEcCtD
Prasugrel—Fatigue—Irinotecan—colon cancer	0.000345	0.00575	CcSEcCtD
Prasugrel—Angiopathy—Capecitabine—colon cancer	0.000342	0.0057	CcSEcCtD
Prasugrel—Dyspnoea—Fluorouracil—colon cancer	0.000341	0.00569	CcSEcCtD
Prasugrel—CYP2C19—liver—colon cancer	0.000341	0.0225	CbGeAlD
Prasugrel—Immune system disorder—Capecitabine—colon cancer	0.00034	0.00567	CcSEcCtD
Prasugrel—Mediastinal disorder—Capecitabine—colon cancer	0.000339	0.00566	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000331	0.00551	CcSEcCtD
Prasugrel—CYP3A4—renal system—colon cancer	0.00033	0.0218	CbGeAlD
Prasugrel—ALB—lymph node—colon cancer	0.000325	0.0214	CbGeAlD
Prasugrel—Body temperature increased—Vincristine—colon cancer	0.000325	0.00541	CcSEcCtD
Prasugrel—Back pain—Capecitabine—colon cancer	0.000317	0.00529	CcSEcCtD
Prasugrel—CYP2B6—vagina—colon cancer	0.000316	0.0209	CbGeAlD
Prasugrel—Body temperature increased—Irinotecan—colon cancer	0.000316	0.00527	CcSEcCtD
Prasugrel—Anaemia—Capecitabine—colon cancer	0.000303	0.00505	CcSEcCtD
Prasugrel—Body temperature increased—Fluorouracil—colon cancer	0.000303	0.00505	CcSEcCtD
Prasugrel—Hypersensitivity—Vincristine—colon cancer	0.000302	0.00504	CcSEcCtD
Prasugrel—Haematuria—Methotrexate—colon cancer	0.000298	0.00497	CcSEcCtD
Prasugrel—Epistaxis—Methotrexate—colon cancer	0.000295	0.00491	CcSEcCtD
Prasugrel—Hypersensitivity—Irinotecan—colon cancer	0.000295	0.00491	CcSEcCtD
Prasugrel—Asthenia—Vincristine—colon cancer	0.000295	0.00491	CcSEcCtD
Prasugrel—Leukopenia—Capecitabine—colon cancer	0.000293	0.00489	CcSEcCtD
Prasugrel—Asthenia—Irinotecan—colon cancer	0.000287	0.00478	CcSEcCtD
Prasugrel—Cough—Capecitabine—colon cancer	0.000286	0.00477	CcSEcCtD
Prasugrel—Hypertension—Capecitabine—colon cancer	0.000283	0.00472	CcSEcCtD
Prasugrel—Hypersensitivity—Fluorouracil—colon cancer	0.000282	0.0047	CcSEcCtD
Prasugrel—Haemoglobin—Methotrexate—colon cancer	0.000282	0.0047	CcSEcCtD
Prasugrel—Diarrhoea—Vincristine—colon cancer	0.000281	0.00468	CcSEcCtD
Prasugrel—Haemorrhage—Methotrexate—colon cancer	0.00028	0.00468	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000277	0.00462	CcSEcCtD
Prasugrel—Urinary tract disorder—Methotrexate—colon cancer	0.000277	0.00462	CcSEcCtD
Prasugrel—Urethral disorder—Methotrexate—colon cancer	0.000275	0.00458	CcSEcCtD
Prasugrel—Diarrhoea—Irinotecan—colon cancer	0.000274	0.00456	CcSEcCtD
Prasugrel—Dizziness—Vincristine—colon cancer	0.000271	0.00453	CcSEcCtD
Prasugrel—CYP3A4—digestive system—colon cancer	0.00027	0.0178	CbGeAlD
Prasugrel—CYP2B6—liver—colon cancer	0.000267	0.0176	CbGeAlD
Prasugrel—Dizziness—Irinotecan—colon cancer	0.000264	0.00441	CcSEcCtD
Prasugrel—CYP2C9—liver—colon cancer	0.000264	0.0174	CbGeAlD
Prasugrel—Eye disorder—Methotrexate—colon cancer	0.000262	0.00437	CcSEcCtD
Prasugrel—Diarrhoea—Fluorouracil—colon cancer	0.000262	0.00437	CcSEcCtD
Prasugrel—Thrombocytopenia—Capecitabine—colon cancer	0.000262	0.00437	CcSEcCtD
Prasugrel—Skin disorder—Capecitabine—colon cancer	0.00026	0.00433	CcSEcCtD
Prasugrel—Rash—Vincristine—colon cancer	0.000259	0.00432	CcSEcCtD
Prasugrel—Dermatitis—Vincristine—colon cancer	0.000259	0.00431	CcSEcCtD
Prasugrel—Headache—Vincristine—colon cancer	0.000257	0.00429	CcSEcCtD
Prasugrel—Angiopathy—Methotrexate—colon cancer	0.000254	0.00424	CcSEcCtD
Prasugrel—Immune system disorder—Methotrexate—colon cancer	0.000253	0.00422	CcSEcCtD
Prasugrel—Dizziness—Fluorouracil—colon cancer	0.000253	0.00422	CcSEcCtD
Prasugrel—Mediastinal disorder—Methotrexate—colon cancer	0.000253	0.00421	CcSEcCtD
Prasugrel—Rash—Irinotecan—colon cancer	0.000252	0.0042	CcSEcCtD
Prasugrel—Dermatitis—Irinotecan—colon cancer	0.000252	0.0042	CcSEcCtD
Prasugrel—Headache—Irinotecan—colon cancer	0.00025	0.00418	CcSEcCtD
Prasugrel—Hypotension—Capecitabine—colon cancer	0.00025	0.00417	CcSEcCtD
Prasugrel—Nausea—Vincristine—colon cancer	0.000244	0.00407	CcSEcCtD
Prasugrel—Rash—Fluorouracil—colon cancer	0.000241	0.00403	CcSEcCtD
Prasugrel—Dermatitis—Fluorouracil—colon cancer	0.000241	0.00402	CcSEcCtD
Prasugrel—Headache—Fluorouracil—colon cancer	0.00024	0.004	CcSEcCtD
Prasugrel—Dyspnoea—Capecitabine—colon cancer	0.000239	0.00398	CcSEcCtD
Prasugrel—Nausea—Irinotecan—colon cancer	0.000237	0.00396	CcSEcCtD
Prasugrel—Back pain—Methotrexate—colon cancer	0.000236	0.00394	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Capecitabine—colon cancer	0.000231	0.00385	CcSEcCtD
Prasugrel—Fatigue—Capecitabine—colon cancer	0.000231	0.00385	CcSEcCtD
Prasugrel—Nausea—Fluorouracil—colon cancer	0.000227	0.00379	CcSEcCtD
Prasugrel—Anaemia—Methotrexate—colon cancer	0.000226	0.00376	CcSEcCtD
Prasugrel—Leukopenia—Methotrexate—colon cancer	0.000218	0.00364	CcSEcCtD
Prasugrel—Cough—Methotrexate—colon cancer	0.000213	0.00355	CcSEcCtD
Prasugrel—Body temperature increased—Capecitabine—colon cancer	0.000212	0.00353	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000206	0.00344	CcSEcCtD
Prasugrel—CYP3A4—liver—colon cancer	0.000201	0.0133	CbGeAlD
Prasugrel—Anaphylactic shock—Methotrexate—colon cancer	0.000199	0.00332	CcSEcCtD
Prasugrel—Hypersensitivity—Capecitabine—colon cancer	0.000197	0.00329	CcSEcCtD
Prasugrel—Thrombocytopenia—Methotrexate—colon cancer	0.000195	0.00325	CcSEcCtD
Prasugrel—Skin disorder—Methotrexate—colon cancer	0.000193	0.00323	CcSEcCtD
Prasugrel—Asthenia—Capecitabine—colon cancer	0.000192	0.0032	CcSEcCtD
Prasugrel—Hypotension—Methotrexate—colon cancer	0.000186	0.0031	CcSEcCtD
Prasugrel—Diarrhoea—Capecitabine—colon cancer	0.000183	0.00305	CcSEcCtD
Prasugrel—Dyspnoea—Methotrexate—colon cancer	0.000178	0.00296	CcSEcCtD
Prasugrel—Dizziness—Capecitabine—colon cancer	0.000177	0.00295	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Methotrexate—colon cancer	0.000172	0.00287	CcSEcCtD
Prasugrel—Fatigue—Methotrexate—colon cancer	0.000172	0.00286	CcSEcCtD
Prasugrel—Rash—Capecitabine—colon cancer	0.000169	0.00281	CcSEcCtD
Prasugrel—Dermatitis—Capecitabine—colon cancer	0.000169	0.00281	CcSEcCtD
Prasugrel—Headache—Capecitabine—colon cancer	0.000168	0.0028	CcSEcCtD
Prasugrel—Nausea—Capecitabine—colon cancer	0.000159	0.00265	CcSEcCtD
Prasugrel—Body temperature increased—Methotrexate—colon cancer	0.000157	0.00263	CcSEcCtD
Prasugrel—Hypersensitivity—Methotrexate—colon cancer	0.000147	0.00245	CcSEcCtD
Prasugrel—Asthenia—Methotrexate—colon cancer	0.000143	0.00238	CcSEcCtD
Prasugrel—Diarrhoea—Methotrexate—colon cancer	0.000136	0.00227	CcSEcCtD
Prasugrel—Dizziness—Methotrexate—colon cancer	0.000132	0.0022	CcSEcCtD
Prasugrel—Rash—Methotrexate—colon cancer	0.000126	0.00209	CcSEcCtD
Prasugrel—Dermatitis—Methotrexate—colon cancer	0.000125	0.00209	CcSEcCtD
Prasugrel—Headache—Methotrexate—colon cancer	0.000125	0.00208	CcSEcCtD
Prasugrel—Nausea—Methotrexate—colon cancer	0.000118	0.00197	CcSEcCtD
